Intradural extramedullary spinal metastases from uterine carcinosarcoma: A case report
-
Received: ,
Accepted: ,
Abstract
Background:
In recent years, improvements in oncological care have led to an increased incidence of intradural extramedullary spinal metastases (IESMs) attributed to uterine carcinosarcoma (UCS). When such lesions occur, they typically carry a poor prognosis. Here, we have evaluated newer treatments, management strategies, and outcomes for IESM due to UCS.Case Description:
A 59-year-old female with a history of recurrent UCS presented with the new onset of the left lower extremity pain, numbness, and episodic urinary incontinence. When the MR revealed an enhancing intradural extramedullary mass posterior to the L1 vertebral body, she underwent a focal decompressive laminectomy. Although she improved neurologically postoperatively, she succumbed to the leptomeningeal spread of her disease within 2 postoperative months.Conclusion:
Management of IESM due to UCS requires multifaceted, individualized treatment modalities, including neurosurgery, radiation therapy, and medical oncologic management to maximize outcomes.Keywords
INTRODUCTION
Intradural extramedullary spinal cord metastases (IESMs) from various types of cancers are uncommon; they are found at autopsy in less than 5% of all cancer patients.[8] IESMs are often drop lesions from intracranial metastases, typically attributed to lung adenocarcinoma, prostate cancer, breast cancer, melanoma, or lymphoma. Here, however, we present a case of IESM due to uterine carcinosarcoma (UCS).
CASE REPORT
A 59-year-old morbidly obese, African-American female had a history of Stage IIIc recurrent endometrial carcinosarcoma with para-aortic and pelvic lymph node involvement. Over several years, after initial surgery, she required repeated bouts of chemotherapy and radiation therapy. She now, however, newly presented with a 1-month history of numbness of the left vulva, worsening left lower extremity pain/numbness, and episodic urinary incontinence. The thoracic/lumbar MR revealed a 1.4 × 1.8 cm enhancing intradural extramedullary mass inferior to the conus at the L1 and L4-L5 levels. In addition, there was abnormal enhancement of the left-sided intradural nerve roots, and the bilateral, perihilar lung metastases [Figure 1].
Surgery
The patient underwent a T12-L2 laminectomy for gross total resection of the L1 intradural/extramedullary mass; the main aim of surgery was to provide neurological symptomatic relief. Intraoperatively, diffuse carcinomatosis of the cauda equina was observed along with a large lesion located anteroinferior to the conus. Grossly, the tumor appeared vascular and involved multiple, swollen, engorged nerve roots. Dissection ceased (e.g., subtotal resection) once intraoperative electromyographic monitoring showed significant changes while dissecting tumor away from tumor infiltrated, matted nerve roots (e.g., gastrocnemius in particular). The permanent pathology showed a mesenchymal malignant Mullerian mixed tumor (carcinosarcoma) without an epithelial component.
Postoperative course
Although the postoperative MR [Figure 2] revealed residual intradural extramedullary tumor, the pain and numbness improved in her left lower extremity [Figure 2]. Nevertheless, she returned to the hospital 2 weeks later complaining of increased lower extremity symptoms and the new onset of right-sided facial weakness, numbness, and blurry vision. Imaging of the brain and spinal cord revealed leptomeningeal spread of her disease accompanied by hydrocephalus and multiple, new intracranial metastases. Two months later, she succumbed to her metastatic disease.
DISCUSSION
Although extramedullary spinal cord tumors account for more than 70% of intradural spinal cord tumors, metastasis to the extramedullary space is exceedingly rare.[8] UCSs, previously known as malignant mixed Mullerian tumors, are rare uterine metaplastic malignancies that have carcinomatous and sarcomatous elements, and account for less than 5% of all uterine malignancies. Of interest, they occur twice as often in African-American versus Caucasian females.[2,7] More than 10% of patients with UCS present with metastatic disease during their initial evaluation.[2,5] Despite the increased survival from UCS and increased incidence of IESM reported in the literature in recent years, there are no reports of IESM from UCS.
MR study of choice for diagnosing IESM with UCS
MRI has largely replaced computed tomography myelography as the study of choice for diagnosing extramedullary spinal cord lesions. Unfortunately, it is unable to distinguish IESM from primary spinal cord tumors or other non-neoplastic lesions.[1]
Prognosis of IESM due to UCS
Surgery
The diagnosis of an IESM due to metastatic UCS represents significant systemic disease and thus carries a grave prognosis; the mean survival is estimated to be <1 year.[6] A few authors have demonstrated an increased survival rate and significant improvement of pain and neurological deficits in those patients with IESM treated surgically as compared to those patients with IESM treated conservatively.[10] The absence of any prospective studies or randomized controlled trials comparing various treatment modalities for IESM due to UCS makes it difficult to identify whether there is any benefit from surgery. Nevertheless, the primary role of surgery is the preservation of neurological function, without increasing disease-free survival.[10] Of note, similar to intramedullary spinal cord metastases, IESMs secondary to chemosensitive primary tumors may often better respond to chemotherapy.[3,9]
However, there are no clear-cut guidelines regarding the use of chemotherapy and/or radiation therapy to treat IESM secondary to UCS.[4] In fact, we believe that this is the first case report of IESM secondary to UCS in the literature. Our patient underwent subtotal resection of her IESM, which initially resulted in improved neurological status, but expired <3 months following her diagnosis of IESM with diffuse brain metastases.
CONCLUSION
Intradural extramedullary spinal cord metastases are rare complications of cancer and carry a grave prognosis. Here, a patient with an IESM, due to UCS, and a long-standing prior history of UCS metastatic disease, required lumbar decompressive surgery to achieve symptomatic relief, but succumbed to her metastatic UCS disease within 2 postoperative months.
Declaration of patient consent
Patient’s consent not required as patients identity is not disclosed or compromised.Financial support and sponsorship
Nil.Conflicts of interest
There are no conflicts of interest.REFERENCES
- Intradural extramedullary metastasis from papillary carcinoma of thyroid. BMJ Case Rep. 2012;2012:bcr0220125801.
- [Google Scholar]
- Uterine carcinosarcomas-diagnosis and management. Oncol Res Treat. 2018;41:675-9.
- [Google Scholar]
- Intramedullary spinal cord metastasis (ISCM) in renal cell carcinoma: A series of six cases. Ann Oncol. 2001;12:1173-7.
- [Google Scholar]
- Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma. Cochrane Database Syst Rev. 2013;2013:CD006812.
- [Google Scholar]
- Uterine sarcoma: Analysis of 13,089 cases based on surveillance, epidemiology, and end results database. Int J Gynecol Cancer. 2016;26:1098-104.
- [Google Scholar]
- Intradural metastasis to the cauda equina found as the initial presentation of breast cancer: A case report. J Med Case Rep. 2019;13:220.
- [Google Scholar]
- Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus. Cancer. 2003;98:176-86.
- [Google Scholar]
- Part I: Spinal-cord neoplasms-intradural neoplasms. Lancet Oncol. 2007;8:35-45.
- [Google Scholar]
- Intramedullary spinal cord metastasis in breast cancer: Clinical features, diagnosis, and therapeutic consideration. Breast J. 2004;10:532-5.
- [Google Scholar]
- Surgical treatment of spinal intradural carcinoma metastases. Acta Neurochir (Wien). 2012;154:349-57.
- [Google Scholar]
Fulltext Views
17
PDF downloads
10
